Filing Details
- Accession Number:
- 0001179110-10-011221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-01 13:00:00
- Reporting Period:
- 2010-06-30
- Filing Date:
- 2010-07-01
- Accepted Time:
- 2010-07-01 19:33:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061027 | Sunesis Pharmaceuticals Inc | SNSS | Pharmaceutical Preparations (2834) | 943295878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197350 | Eric Bjerkholt | C/O Sunesis Pharmaceuticals, Inc. 395 Oyster Point Boulevard, Suite 400 South San Francisco CA 94080 | Sr. Vp, Cfo & Corp. Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-06-30 | 238,243 | $0.28 | 238,243 | No | 4 | P | Indirect | See Footnote |
| Common Stock | Acquisiton | 2010-06-30 | 99,940 | $0.00 | 338,183 | No | 4 | C | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
| No | 4 | C | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2010-06-30 | 9,994 | $0.00 | 99,940 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,095 | Direct |
Footnotes
- The shares are held in the Bjerkhold/Hahn Family Trust for which reporting person is Trustee.
- The Series A Preferred Stock automatically converted into common stock in accordance with the terms of the applicabale Certificate of Designation of the Issuer on a 1-for-10 basis and had no expiration date.
Billionaire Hedge Funds
